Clinical Trial: Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex
Brief Summary: To compare the efficacy and safety of orally administered didanosine (ddI) with orally administered zidovudine (AZT) in the treatment of patients who exhibit increasing clinical deterioration despite treatment with AZT.
Detailed Summary:
Sponsor: Bristol-Myers Squibb
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Bristol-Myers Squibb
Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: August 4, 2011
Last Verified: August 2011